Finance

Lists
OFSA3:BVMF
Ourofino SA
R$27.00
+0.75%
(+0.20) 1D
Sep 4, 5:03:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for OFSA3...
Open
R$26.69
High
R$27.49
Low
R$26.69
Mkt. cap
1.46B
Avg. vol.
8.11K
Volume
15.00K
P/E ratio
6.15
52-wk high
R$34.69
52-wk low
R$19.83
EPS
R$4.39
Shares outstanding
53.95M
No. of employees
1K
Open
R$26.69
High
R$27.49
Low
R$26.69
Mkt. cap
1.46B
Avg. vol.
8.11K
Volume
15.00K
P/E ratio
6.15
52-wk high
R$34.69
52-wk low
R$19.83
EPS
R$4.39
Shares outstanding
53.95M
No. of employees
1K
About Ourofino SA
CEO-
Employees1.09K
Founded1987
Headquarters-
SectorPharmaceutical industry
Last report
Aug 7, 2026
Fiscal period
Q2 2026
EPS / Est. (BRL)
- / -
Revenue / Est. (BRL)
338.67M / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
356.50M
419.73M
250.47M
338.67M
Cost of goods sold
168.16M
200.21M
115.53M
171.25M
Cost of revenue
168.16M
200.21M
115.53M
171.25M
Research and development expenses
-
59.95M
18.43M
18.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
100.31M
51.89M
80.68M
95.99M
Operating expense
107.96M
107.48M
100.46M
112.38M
Total operating expenses
276.12M
307.69M
215.98M
283.63M
Operating income
80.39M
112.04M
34.49M
55.04M
Other non operating income
-106.00K
-409.00K
-630.00K
-286.00K
EBT including unusual items
75.92M
102.00M
33.23M
26.01M
EBT excluding unusual items
75.92M
107.35M
33.16M
51.57M
Income tax expense
21.19M
-39.29M
11.87M
7.29M
Effective tax rate
27.91%
-38.52%
35.73%
28.04%
Other operating expenses
7.65M
-4.36M
1.34M
-2.03M
Net income
54.73M
141.29M
21.36M
18.72M
Net profit margin
15.35%
33.66%
8.53%
5.53%
Earnings per share
-
-
-
-
Interest and investment income
6.19M
5.05M
8.97M
10.41M
Interest expense
-10.56M
-5.75M
-9.46M
-12.58M
Net interest expenses
-4.38M
-699.00K
-491.00K
-2.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
89.93M
117.27M
39.65M
60.18M
Gain or loss from assets sale
-1.06M
-1.59M
-61.00K
4.30M
AI content may include mistakes. Learn more
Google apps